Medical News

RSS

Chindex revenues increase 21% to $55.5M in second quarter 2014

Chindex International, Inc., an American healthcare company providing premium quality healthcare services in China through the operations of United Family Healthcare ("UFH"), a network of private primary care hospitals and affiliated ambulatory clinics, today announced financial results for the second quarter ended June 30, 2014.

11 Aug 2014

ResMed releases new forward-thinking connected care solution for SDB treatment

ResMed today announced Air Solutions, a new forward-thinking connected care solution for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum. The ResMed Air Solutions platform has data-driven components that span from diagnosis to treatment, compliance management and patient engagement.

From ResMed Corp 11 Aug 2014

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes.

11 Aug 2014

Avillion initiates BOSULIF Phase 3 trial in patients with chronic phase Ph+ CML

Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). The first patient was dosed on July 22, 2014.

11 Aug 2014

Bio-Techne revenue increases 16% to $92.5 million in fourth quarter 2014

Techne Corporation, (d/b/a Bio-Techne) today reported its financial results for the fourth quarter and full year ended June 30, 2014.

From ProteinSimple 11 Aug 2014

Mylan announces launch of Capecitabine Tablets USP, 150 mg and 500 mg

Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.

11 Aug 2014

New method could make cashews safer for people with allergies

For the millions of adults and children in the U.S. who have to shun nuts to avoid an allergic reaction, help could be on the way. Scientists are now developing a method to process cashews - and potentially other nuts - that could make them safer to eat for people who are allergic to them.

11 Aug 2014

Scientists identify mechanism by which inherited neurological disease causes muscle weakness in men

Researchers at University of California, San Diego School of Medicine have identified the mechanism by which a rare, inherited neurodegenerative disease causes often crippling muscle weakness in men, in addition to reduced fertility.

11 Aug 2014

US lung cancer rates uncover trends related to cancer subtype, sex, race/ethnicity and age

A new analysis confirms that US lung cancer rates are declining overall, but it also uncovers previously unrecognized trends related to cancer subtype, sex, race/ethnicity, and age.

11 Aug 2014

Patient with mechanical heart pump receives new gene therapy for heart failure

For the first time in the world, a patient with a mechanical heart pump has received a new gene therapy for heart failure at Harefield Hospital, London.

11 Aug 2014

Retina's Alpha IMS microchip receives NUB innovation status from Germany statutory health insurance

Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that the Company's Alpha IMS microchip was granted NUB innovation status and will now be reimbursed by Germany's statutory health insurance system.

11 Aug 2014

Demand of materials used to produce smartphones need to be addressed, say researchers

Many of today's technological innovations from the iPhone to electric motors for hybrid cars require the use of materials - elements - that are scarce or difficult to obtain. As demand for these devices grows, the problem of dwindling critical element supplies must be addressed.

11 Aug 2014

Exposure of pregnant women and fetuses to antibacterial compounds leads to health risk

As the Food and Drug Administration (FDA) mulls over whether to rein in the use of common antibacterial compounds that are causing growing concern among environmental health experts, scientists are reporting today that many pregnant women and their fetuses are being exposed to these substances.

11 Aug 2014

Black and Hispanic SLE patients are more likely to be readmitted than white patients

A new study reveals that one in six patients with systemic lupus erythematosus (SLE) is readmitted to the hospital within 30 days of being discharged.

11 Aug 2014

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

Regeneron Pharmaceuticals, Inc. today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema.

11 Aug 2014

Regular physical activity decreases risk for invasive breast cancer among postmenopausal women

Postmenopausal women who in the past four years had undertaken regular physical activity equivalent to at least four hours of walking per week had a lower risk for invasive breast cancer compared with women who exercised less during those four years, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

11 Aug 2014

Breech births increase fetal mortality rate compared to elective vaginal delivery

While a rise in cesarean section (C-section) delivery rates due to breech presentation has improved neonatal outcome, 40% of term breech deliveries in the Netherlands are planned vaginal deliveries.

11 Aug 2014

Study of quality of life provides answers to what really brings happiness to consumers

The pursuit of true happiness can lead people to lifestyles that will not only be satisfying but will be better for the environment, according to an overview of psychological research presented at the American Psychological Association's 122nd Annual Convention.

11 Aug 2014

Frequent marijuana use can have negative effect on brains of teenagers

Frequent marijuana use can have a significant negative effect on the brains of teenagers and young adults, including cognitive decline, poor attention and memory, and decreased IQ, according to psychologists discussing public health implications of marijuana legalization at the American Psychological Association's 122nd Annual Convention.

11 Aug 2014

Nearly 40% of women who earn engineering degrees quit profession or never enter the field

Nearly 40 percent of women who earn engineering degrees quit the profession or never enter the field, and for those who leave, poor workplace climates and mistreatment by managers and co-workers are common reasons, according to research presented at the American Psychological Association's 122nd Annual Convention.

11 Aug 2014

Medical News

Chindex revenues increase 21% to $55.5M in second quarter 2014

ResMed releases new forward-thinking connected care solution for SDB treatment

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Avillion initiates BOSULIF Phase 3 trial in patients with chronic phase Ph+ CML

Bio-Techne revenue increases 16% to $92.5 million in fourth quarter 2014

Mylan announces launch of Capecitabine Tablets USP, 150 mg and 500 mg

New method could make cashews safer for people with allergies

Scientists identify mechanism by which inherited neurological disease causes muscle weakness in men

US lung cancer rates uncover trends related to cancer subtype, sex, race/ethnicity and age

Patient with mechanical heart pump receives new gene therapy for heart failure

Retina's Alpha IMS microchip receives NUB innovation status from Germany statutory health insurance

Demand of materials used to produce smartphones need to be addressed, say researchers

Exposure of pregnant women and fetuses to antibacterial compounds leads to health risk

Black and Hispanic SLE patients are more likely to be readmitted than white patients

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

Regular physical activity decreases risk for invasive breast cancer among postmenopausal women

Breech births increase fetal mortality rate compared to elective vaginal delivery

Study of quality of life provides answers to what really brings happiness to consumers

Frequent marijuana use can have negative effect on brains of teenagers

Nearly 40% of women who earn engineering degrees quit profession or never enter the field

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News